scholarly article | Q13442814 |
P356 | DOI | 10.3109/00498254.2016.1156186 |
P698 | PubMed publication ID | 27122100 |
P2093 | author name string | Jian Guo | |
Gregory S Basarab | |||
Camil Joubran | |||
Karthick Vishwanathan | |||
Ricardo A Luzietti | |||
Scott W Grimm | |||
P2860 | cites work | Emerging mechanisms of fluoroquinolone resistance | Q24644842 |
Structure and mechanism of DNA topoisomerase II | Q27732221 | ||
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. | Q34214929 | ||
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups | Q35758905 | ||
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system | Q35821755 | ||
Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases. | Q35848139 | ||
Global fluoroquinolone resistance epidemiology and implictions for clinical use. | Q36337074 | ||
Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation | Q36480892 | ||
Bacterial DNA replication enzymes as targets for antibacterial drug discovery | Q37998090 | ||
Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914). | Q38855047 | ||
Synthesis of a tetrahydronaphthyridine spiropyrimidinetrione DNA gyrase inhibiting antibacterial agent--differential substitution at all five carbon atoms of pyridine | Q41627721 | ||
In vitro and in vivo metabolism of 14C-AZ11, a novel inhibitor of bacterial DNA gyrase/type II topoisomerase | Q44147488 | ||
Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study | Q44439017 | ||
Synthesis of (-)-PNU-286607 by asymmetric cyclization of alkylidene barbiturates | Q44556801 | ||
Fluoroquinolones: mechanisms of action and resistance. | Q54249946 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 31-49 | |
P577 | publication date | 2016-04-28 | |
P1433 | published in | Xenobiotica | Q1360678 |
P1476 | title | Absorption, distribution, metabolism and elimination of 14C-ETX0914, a novel inhibitor of bacterial type-II topoisomerases in rodents | |
P478 | volume | 47 |
Q58100697 | Single-dose Pharmacokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers | cites work | P2860 |